Plunkett Research Online: Emergent BioSolutions Inc

EMERGENT BIOSOLUTIONS INC (EBS:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Emergent BioSolutions, Inc. (EB) is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccine and immune-related therapeutics. The firm focuses on developing, manufacturing and commercializing medical countermeasures (MCM) that address public health threat.....



Emergent BioSolutions Inc
Ticker: EBS
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 240-631-3200
Fax:
Address: 400 Professional Drive
Suite 400
Gaithersburg, MD 20879 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines
Biodefense Vaccines
Oncology Therapeutics
ContactsDescription
Daniel Abdun-NabiCEO/Director/President
Robert KramerCFO/Chief Accounting Officer/Executive VP, Divisional
See More
Emergent BioSolutions, Inc. (EB) is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccine and immune-related therapeutics. The firm focuses on developing, manufacturing and commercializing medical countermeasures (MCM) that address public health threat.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
BioThrax
Anthrasil
BAT
VIGIV
RSDL
Trobigard
NuThrax
ZIKA-IG (NP024)
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: